Measuring disability-adjusted life years (DALYs) due to COVID-19 in Scotland, 2020.
Burden of disease
COVID-19
DALY
European burden of disease network
Scottish burden of disease
YLD
YLL
coronavirus
disability-adjusted life years
population health
Journal
Archives of public health = Archives belges de sante publique
ISSN: 0778-7367
Titre abrégé: Arch Public Health
Pays: England
ID NLM: 9208826
Informations de publication
Date de publication:
01 Apr 2022
01 Apr 2022
Historique:
received:
06
01
2022
accepted:
20
03
2022
entrez:
2
4
2022
pubmed:
3
4
2022
medline:
3
4
2022
Statut:
epublish
Résumé
Disability-adjusted life years (DALYs) combine the impact of morbidity and mortality and can enable comprehensive, and comparable, assessments of direct and indirect health harms due to COVID-19. Our aim was to estimate DALYs directly due to COVID-19 in Scotland, during 2020; and contextualise its population impact relative to other causes of disease and injury. National deaths and daily case data were used. Deaths were based on underlying and contributory causes recorded on death certificates. We calculated DALYs based on the COVID-19 consensus model and methods outlined by the European Burden of Disease Network. DALYs were presented as a range, using a sensitivity analysis based on Years of Life Lost estimates using: cause-specific; and COVID-19 related deaths. All COVID-19 estimates were for 2020. In 2020, estimates of COVID-19 DALYs in Scotland ranged from 96,500 to 108,200. Direct COVID-19 DALYs were substantial enough to be framed as the second leading cause of disease and injury, with only ischaemic heart disease having a larger impact on population health. Mortality contributed 98% of total DALYs. The direct population health impact of COVID-19 has been very substantial. Despite unprecedented mitigation efforts, COVID-19 developed from a single identified case in early 2020 to a condition with an impact in Scotland second only to ischaemic heart disease. Periodic estimation of DALYs during 2021, and beyond, will provide indications of the impact of DALYs averted due to the national rollout of the vaccination programme and other continued mitigation efforts, although new variants may pose significant challenges.
Sections du résumé
BACKGROUND
BACKGROUND
Disability-adjusted life years (DALYs) combine the impact of morbidity and mortality and can enable comprehensive, and comparable, assessments of direct and indirect health harms due to COVID-19. Our aim was to estimate DALYs directly due to COVID-19 in Scotland, during 2020; and contextualise its population impact relative to other causes of disease and injury.
METHODS
METHODS
National deaths and daily case data were used. Deaths were based on underlying and contributory causes recorded on death certificates. We calculated DALYs based on the COVID-19 consensus model and methods outlined by the European Burden of Disease Network. DALYs were presented as a range, using a sensitivity analysis based on Years of Life Lost estimates using: cause-specific; and COVID-19 related deaths. All COVID-19 estimates were for 2020.
RESULTS
RESULTS
In 2020, estimates of COVID-19 DALYs in Scotland ranged from 96,500 to 108,200. Direct COVID-19 DALYs were substantial enough to be framed as the second leading cause of disease and injury, with only ischaemic heart disease having a larger impact on population health. Mortality contributed 98% of total DALYs.
CONCLUSIONS
CONCLUSIONS
The direct population health impact of COVID-19 has been very substantial. Despite unprecedented mitigation efforts, COVID-19 developed from a single identified case in early 2020 to a condition with an impact in Scotland second only to ischaemic heart disease. Periodic estimation of DALYs during 2021, and beyond, will provide indications of the impact of DALYs averted due to the national rollout of the vaccination programme and other continued mitigation efforts, although new variants may pose significant challenges.
Identifiants
pubmed: 35365228
doi: 10.1186/s13690-022-00862-x
pii: 10.1186/s13690-022-00862-x
pmc: PMC8972687
doi:
Types de publication
Journal Article
Langues
eng
Pagination
105Informations de copyright
© 2022. The Author(s).
Références
J Epidemiol Community Health. 2019 Oct;73(10):971-974
pubmed: 31326891
BMC Public Health. 2021 Oct 9;21(1):1827
pubmed: 34627228
Med Hypotheses. 2020 Nov;144:110055
pubmed: 32758891
Arch Public Health. 2016 Aug 22;74:37
pubmed: 27551405
Eur J Epidemiol. 2022 Feb;37(2):215-216
pubmed: 35244840
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
BMJ. 2020 Apr 27;369:m1557
pubmed: 32341002
Int J Public Health. 2020 Jul;65(6):719-720
pubmed: 32691080
Int J Public Health. 2021 Mar 05;66:619011
pubmed: 34744580
J Epidemiol Glob Health. 2016 Jun;6(2):119-21
pubmed: 27001076
Wellcome Open Res. 2020 Apr 23;5:75
pubmed: 33709037
Trends Parasitol. 2019 Sep;35(9):673-676
pubmed: 31279656
Popul Health Metr. 2015 Apr 03;13:10
pubmed: 26778920
BMJ. 2020 May 22;369:m1985
pubmed: 32444460
BMJ. 2020 Jul 14;370:m2815
pubmed: 32665317
PLoS One. 2018 Aug 1;13(8):e0196906
pubmed: 30067740
Bull World Health Organ. 2000;78(8):981-94
pubmed: 10994282
BMJ Open. 2019 Oct 31;9(10):e029936
pubmed: 31676648
PLoS Curr. 2013 Sep 06;5:
pubmed: 24056956
Dtsch Arztebl Int. 2021 Mar 5;118(9):145-151
pubmed: 33958032
J Korean Med Sci. 2020 Jun 01;35(21):e199
pubmed: 32476305
PLoS One. 2019 Aug 9;14(8):e0221026
pubmed: 31398232
PLoS Negl Trop Dis. 2021 Jan 4;15(1):e0008958
pubmed: 33395425
J Epidemiol Community Health. 2020 Nov 3;:
pubmed: 33144334
Epidemics. 2014 Dec;9:52-61
pubmed: 25480134
BMJ. 2021 Nov 3;375:e066768
pubmed: 34732390
J Epidemiol Community Health. 2020 Sep;74(9):741-746
pubmed: 32385127